Immunomedics, Inc. (IMMU) Forms $14.61 Double Top; Parametric Portfolio Associates Raised Orix Sponsored Adr (IX) Position By $3.16 Million

ORIX Corporation (NYSE:IX) Logo

Immunomedics, Inc. (IMMU) formed double top with $15.78 target or 8.00% above today’s $14.61 share price. Immunomedics, Inc. (IMMU) has $2.42B valuation. The stock increased 0.97% or $0.14 during the last trading session, reaching $14.61. About 1.75M shares traded. Immunomedics, Inc. (NASDAQ:IMMU) has risen 117.70% since April 2, 2017 and is uptrending. It has outperformed by 106.15% the S&P500.

Parametric Portfolio Associates Llc increased Orix Corp Sponsored Adr (IX) stake by 10.1% reported in 2017Q4 SEC filing. Parametric Portfolio Associates Llc acquired 37,665 shares as Orix Corp Sponsored Adr (IX)’s stock rose 3.00%. The Parametric Portfolio Associates Llc holds 410,678 shares with $34.82M value, up from 373,013 last quarter. Orix Corp Sponsored Adr now has $22.41B valuation. The stock increased 1.61% or $1.42 during the last trading session, reaching $89.86. About 20,285 shares traded. ORIX Corporation (NYSE:IX) has risen 15.29% since April 2, 2017 and is uptrending. It has outperformed by 3.74% the S&P500.

Parametric Portfolio Associates Llc decreased Chemical Financial Corp (NASDAQ:CHFC) stake by 31,182 shares to 175,898 valued at $9.41M in 2017Q4. It also reduced Rite Aid Corp Com (NYSE:RAD) stake by 389,242 shares and now owns 3.01 million shares. Vista Outdoor Inc was reduced too.

Investors sentiment decreased to 1.07 in 2017 Q4. Its down 0.58, from 1.65 in 2017Q3. It dived, as 27 investors sold Immunomedics, Inc. shares while 44 reduced holdings. 29 funds opened positions while 47 raised stakes. 117.18 million shares or 4.91% more from 111.69 million shares in 2017Q3 were reported. Highland Cap Mgmt Ltd Partnership invested 0.05% of its portfolio in Immunomedics, Inc. (NASDAQ:IMMU). Renaissance Tech Ltd Liability holds 230,474 shares or 0% of its portfolio. Victory Cap Mgmt Inc stated it has 1.11 million shares or 0.04% of all its holdings. Tower Cap Limited (Trc) holds 0% or 149 shares. Pictet Asset Mngmt Ltd, United Kingdom-based fund reported 1.62M shares. Barclays Public Ltd Company reported 261,736 shares. The Maryland-based Proshare Advisors Ltd Com has invested 0.01% in Immunomedics, Inc. (NASDAQ:IMMU). The Colorado-based Alps has invested 0.02% in Immunomedics, Inc. (NASDAQ:IMMU). Pnc Fincl Services Group reported 5,721 shares. Great West Life Assurance Can holds 21,882 shares. Hanseatic Management Services holds 0% of its portfolio in Immunomedics, Inc. (NASDAQ:IMMU) for 195 shares. Panagora Asset Management has invested 0.04% in Immunomedics, Inc. (NASDAQ:IMMU). California State Teachers Retirement System invested 0.01% of its portfolio in Immunomedics, Inc. (NASDAQ:IMMU). Rhenman & Partners Asset Mngmt Ab holds 480,330 shares. Eam Ltd Liability owns 131,382 shares.

Analysts await Immunomedics, Inc. (NASDAQ:IMMU) to report earnings on May, 9. They expect $-0.13 earnings per share, up 40.91% or $0.09 from last year’s $-0.22 per share. After $-0.19 actual earnings per share reported by Immunomedics, Inc. for the previous quarter, Wall Street now forecasts -31.58% EPS growth.

Among 3 analysts covering Immunomedics (NASDAQ:IMMU), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Immunomedics has $16 highest and $1.50 lowest target. $15.50’s average target is 6.09% above currents $14.61 stock price. Immunomedics had 15 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Tuesday, March 15 by Jefferies. The company was downgraded on Friday, December 4 by Wells Fargo. The firm has “Buy” rating by Jefferies given on Tuesday, September 19. The company was maintained on Monday, July 24 by Cowen & Co. The company was downgraded on Wednesday, July 29 by Jefferies. The rating was maintained by Cowen & Co with “Buy” on Wednesday, August 16. The rating was upgraded by Jefferies to “Buy” on Friday, May 6. The firm has “Buy” rating given on Wednesday, December 6 by Jefferies. The company was maintained on Monday, October 9 by Jefferies. As per Tuesday, June 21, the company rating was downgraded by Wells Fargo.

Since February 28, 2018, it had 0 buys, and 1 sale for $2.05 million activity. 117,729 shares were sold by GOLDENBERG DAVID M, worth $2.05M on Wednesday, February 28.

Immunomedics, Inc. (NASDAQ:IMMU) Institutional Positions Chart